Turkish Journal of Medical Sciences
Volume 47

Number 2

Article 45

1-1-2017

Effects of Ankaferd BloodStopper on dermal healing in diabetic
rats
SERTAÇ AKTOP
BURCU ÇEVRELİ
DENİZ GENÇ
EMEL SERDAROĞLU KAŞIKÇI
NİL ÇOMUNOĞLU ÜSTÜNDAĞ

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
AKTOP, SERTAÇ; ÇEVRELİ, BURCU; GENÇ, DENİZ; KAŞIKÇI, EMEL SERDAROĞLU; ÜSTÜNDAĞ, NİL
ÇOMUNOĞLU; ZİBANDEH, NOUSHİN; ÖZCAN, ELİF MERVE; GÖÇMEN, GÖKHAN; GÖKER, MEHMET
KAMİL; UZBAY, İSMAİL TAYFUN; and AKKOÇ, TUNÇ (2017) "Effects of Ankaferd BloodStopper on dermal
healing in diabetic rats," Turkish Journal of Medical Sciences: Vol. 47: No. 2, Article 45. https://doi.org/
10.3906/sag-1604-145
Available at: https://journals.tubitak.gov.tr/medical/vol47/iss2/45

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Effects of Ankaferd BloodStopper on dermal healing in diabetic rats
Authors
SERTAÇ AKTOP, BURCU ÇEVRELİ, DENİZ GENÇ, EMEL SERDAROĞLU KAŞIKÇI, NİL ÇOMUNOĞLU
ÜSTÜNDAĞ, NOUSHİN ZİBANDEH, ELİF MERVE ÖZCAN, GÖKHAN GÖÇMEN, MEHMET KAMİL GÖKER,
İSMAİL TAYFUN UZBAY, and TUNÇ AKKOÇ

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol47/iss2/45

Turkish Journal of Medical Sciences

Turk J Med Sci
(2017) 47: 675-680
© TÜBİTAK
doi:10.3906/sag-1604-145

http://journals.tubitak.gov.tr/medical/

Research Article

Effects of Ankaferd BloodStopper on dermal healing in diabetic rats
1,

2

3

4

5

Sertaç AKTOP *, Burcu ÇEVRELİ , Deniz GENÇ , Emel SERDAROĞLU KAŞIKÇI , Nil ÇOMUNOĞLU ÜSTÜNDAĞ ,
3
1
1
1
4
3
Noushin ZİBANDEH , Elif Merve ÖZCAN , Gökhan GÖÇMEN , Mehmet Kamil GÖKER , İsmail Tayfun UZBAY , Tunç AKKOÇ
1
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Marmara University, İstanbul, Turkey
2
Experimental Research Unit, Faculty of Engineering and Natural Sciences, Üsküdar University, İstanbul, Turkey
3
Department of Pediatric Allergy and Immunology, Faculty of Medicine, Marmara University, İstanbul, Turkey
4
Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Üsküdar University, İstanbul, Turkey
5
Department of Medical Pathology, Cerrahpaşa Faculty of Medicine, İstanbul University, İstanbul, Turkey
Received: 29.04.2016

Accepted/Published Online: 11.09.2016

Final Version: 18.04.2017

Background/aim: Diabetes mellitus inhibits wound-induced angiogenesis, impairs the wound healing process, and leads to the
development of chronic wounds. Ankaferd BloodStopper (ABS) is a new and promising local haemostatic agent. Although the
mechanism of ABS-mediated haemostasis is well established, little is known about the associated histological and biochemical tissue
reactions. The aim of this study was to evaluate the effects of this new-generation local haemostatic agent on short-term soft-tissue
healing in streptozotocin (STZ)-treated rats.
Materials and methods: The 24 Wistar albino rats used in this study were divided into STZ-treated (STZ, n = 12) and nontreated groups
(control, n = 12). Four days prior to surgery, rats in the STZ group were subcutaneously administered 60 mg/kg STZ intraperitoneally,
while rats in the control group were administered 1 mL saline/kg. An incision was made in the dorsal dermal tissue of all rats, and either
ABS or no haemostatic agent (NHAA) was applied to the wound before suturing. All of the rats were euthanised on postoperative day
4. Blood and skin samples were evaluated biochemically and histologically.
Results: The results showed that STZ treatment impaired soft-tissue healing, assessed by measuring glutathione and lipid peroxidation
levels. Moreover, while good histological results were obtained in the control group treated with ABS, there were fewer benefits in the
STZ-treated group.
Conclusion: ABS’s benefits in the control group seemed to lose their effectiveness under STZ medication.
Key words: Streptozotocin, Ankaferd BloodStopper, glutathione, lipid peroxidation, vascular endothelial growth factor, transforming
growth factor-beta

1. Introduction
Diabetes mellitus (DM) is a chronic, life-long metabolic
disease occurring worldwide. Affected individuals require
continuous follow-up and suffer numerous disease-related
complications. The high levels of blood glucose that
characterise DM contribute to an increase in free radical
production, enhanced oxidative stress, and changes in
antioxidant capacity (1–3).
Streptozotocin (STZ) is the chemical agent most
frequently used to induce experimental diabetes in animal
models. By binding to glucose receptors in the plasma
membrane, STZ blocks glucose-induced insulin secretion
(2,3) and alters blood insulin and glucose concentrations.
Among the many effects of free radical production
is lipid peroxidation (LPO). Oxidation of membrane
polyunsaturated fatty acids disrupts cell structure and
* Correspondence: sertacaktop@hotmail.com

function and induces cytotoxic, hepatotoxic, mutagenic,
and genotoxic effects related to the release of aldehydes
(4,5).
The tripeptide glutathione (GSH) is found in the cells
of all organisms. In humans, GSH concentrations are
highest in the liver; in hepatocytes, GSH accounts for 90%
of nonprotein sulfhydryl groups. As an important reducing
agent and antioxidant, GSH maintains the cellular oxidoreduction balance and protects cells against the toxic
effects of oxidants, whether of endogenous or exogenous
origin (5–7).
Ankaferd BloodStopper (ABS) (Ankaferd Health
Products Ltd., İstanbul, Turkey) is a medicinal extract
from the plants Thymus vulgaris, Glycyrrhiza glabra,
Vitis vinifera, Alpinia officinarum, and Urtica dioica (7,8).
ABS is not only an effective haemostatic agent but also

675

AKTOP et al. / Turk J Med Sci
exhibits tissue antioxidant properties (5,9). In Turkey, ABS
is approved for the management of postsurgical dental
bleeding and external haemorrhage (5). ABS forms an
encapsulated protein providing focal points for erythrocyte
aggregation, without affecting other components of the
coagulant system.
Studies on wound healing often involve assessments
of collagen, a protein crucial to restoring the integrity
of the skin (10,11), and angiogenesis, in which vascular
endothelial growth factor (VEGF) and transforming
growth factor-beta (TGF-β) play prominent roles (12,13).
VEGF controls a variety of endothelial cell functions
involved in angiogenesis and protects these cells from
apoptosis (14). Fibroblast growth factor-2 (FGF-2) and
TGF-β induce VEGF expression in vascular endothelial
cells (15). In addition, TGF-β is an important regulator
of tissue morphogenesis and a potent inhibitor of
proliferation for most cell types (13).
Several studies have shown that ABS promotes tissue
healing (5,9,16–21). Therefore, in this study, we addressed
the effectiveness of ABS in diabetes, in which wound
healing is severely impaired. Specifically, we evaluated the
effects of ABS on short-term dermal soft-tissue healing in
rats with STZ-induced diabetes.
2. Materials and methods
2.1. Animals and treatment
Twenty-four male Wistar albino rats weighing 280–450 g
were divided into STZ-treated and control groups (n = 12
each). The animals were obtained from the Department
of Experimental Research Unit, Üsküdar University
(İstanbul, Turkey), where the surgery and postoperative
care were performed. All experimental protocols were
approved by the Animal Care and Use Ethical Committee
of Marmara University (no: 40.2013.mar)
The 12 control rats were injected subcutaneously with
1 mL saline/kg intraperitoneally and the 12 rats in the STZ
group were injected subcutaneously with a single dose
of STZ (60 mg/kg, freshly dissolved in 1 mL of saline)
intraperitoneally 4 days before surgery. In the latter group,
the animals were considered to be diabetic, based on
blood glucose levels ≥250 mg/dL. All 24 rats underwent
surgery and on postoperative day 4 were euthanised by the
injection of a high dose of anaesthetic.
The animals were anaesthetised with a combination
of 90 mg/kg ketamine (Ketalar, Pfizer İlaçları Ltd. Şti,
İstanbul, Turkey) and 10 mg/kg xylazine (Rompun,
Bayer HealthCare, Leverkusen, Germany). Surgery was
performed under aseptic conditions.
The dorsal skin was shaved, and an incision 2 cm long
and perpendicular to the head-to-tail direction was made.
In 6 of the 12 animals in each group, the wounds were
sutured without application of haemostatic agent and left
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to heal naturally. The incisions of the other 6 animals were
treated with 0.25 ml ABS, applied before suturing.
The dorsal skin was excised completely from the
euthanised animals, and the wounded tissue area was
prepared for histological evaluation at the Department
of Medical Pathology, Cerrahpaşa Faculty of Medicine,
İstanbul University (İstanbul, Turkey). Blood samples taken
from the euthanised animals were used in biochemical
evaluations, performed at the Department of Molecular
Biology and Genetics, Faculty of Engineering and Natural
Sciences, Üsküdar University (İstanbul, Turkey).
2.2. Biochemical tests
Blood GSH concentrations were determined according
to the method of Beutler, using metaphosphoric acid for
protein precipitation and 5’5’-dithiobis-2-nitro-benzoic
acid for colour development (22). Blood LPO levels were
assayed by measuring serum malondialdehyde levels,
determined as thiobarbituric acid reactive substances
according to the method described by Yagi (23).
2.3. Histological evaluation
Surgical specimens were fixed in 10% neutral buffered
formalin, processed routinely, and embedded in
paraffin blocks. The 4-µm-thick sections cut from the
blocks were stained with haematoxylin and eosin. In
addition, 4- to 6-µm-thick sections were cut, floated
on positively charged microscope slides, and labelled
with an indirect avidin-biotin-peroxidase complex for
automated immunohistochemistry analysis (Ventana
Medical Systems, Tucson, AZ, USA). Tissue sections were
deparaffinised, rehydrated in decreasing concentrations
of alcohol, and washed with distilled water. Antigen
retrieval was achieved by incubating the slides in 10
mM sodium citrate at 36 °C for 30 min. The slides were
then incubated for 1 h with TGF-β rabbit polyclonal
antibody (1:500, Abcam, Cambridge, UK), VEGF rabbit
polyclonal antibody (1 µg/mL, Abcam), and collagen 4
rabbit polyclonal antibody (1/1000, Abcam) and then
counterstained with haematoxylin. Positive controls for
TGF-β, VEGF, and collagen consisted of human placental
tissue, haemangioma tissue, and human epidermal
keratinocyte lysate, respectively. The negative control
consisted of PBS instead of the primary antibody.
2.3.1. Histological scoring
Immunostaining was scored by a pathologist blinded to
the clinical data and was evaluated using a double-headed
BHS Olympus microscope. The intensity of staining was
graded as 0, negative; 1+, weak; 2+, moderate; and 3+,
strong. The extent of immunostaining was graded as 0
(0%), negative, 1+ (0%–25%), 2+ (26%–50%), and 3+
(51%–100%).
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2.4. Statistical analysis
All statistical analyses were performed using the Statistical
Package for the Social Sciences, version 22.0 (SPSS,
Chicago, IL, USA). The results were evaluated using the
Shapiro–Wilk test for data with a normal distribution and
are expressed as means ± standard deviation. Quantitative
data that fulfilled the parametric criteria were analysed
using Student’s t test; nonparametric data were analysed
using the Mann–Whitney U test. A P value <0.05 was
considered to indicate statistical significance.
3. Results
3.1. Biochemical results
3.1.1. Comparison of GSH and LPO levels in blood
samples from the control and STZ groups
There were no significant differences in the blood samples
from ABS versus NHAA rats in either the control or
STZ group. The GSH values were significantly higher

in the control group than in the STZ group for both the
NHAA- and the ABS-treated rats (P = 0.0001; P = 0.003,
respectively). LPO values were significantly higher in the
NHAA blood samples of the STZ group than those of the
control group (P = 0.0001). The LPO values in the ABStreated animals were slightly, but not significantly, higher
in the STZ group than in the control group (Table 1).
3.2. Histological results
3.2.1. Comparison of histological scores in tissues of the
control and STZ groups
In the control group, the scores for both the intensity and
extent of collagen 4 staining were significantly higher in
the ABS-treated than in the NHAA-treated tissues of the
control group and the ABS-treated tissues of the STZ
group (P = 0.021 and P = 0.021, respectively). The VEGF
intensity scores within the control group were significantly
higher in ABS-treated than in NHAA-treated tissues (P =
0.034) (Table 2).

Table 1. GSH and LPO levels in blood samples on postoperative day 4.a
Control group (n = 12)

GSH (mg/g p)

STZ group (n = 12)

Mean

±

SD

Mean

±

SD

P

ABS (n = 6)

31.35

±

4.62

18.58

±

3.1

0.0001*

NHAA (n = 6)

42.03

±

10.14

20.52

±

3.01

0.003*

P

0.51

LPO (nmol MDA/mg p)

0.298

ABS (n = 6)

5.95

±

1.7

7.8

±

1.23

0.06

NHAA (n = 6)

5.88

±

0.67

8.52

±

0.82

0.0001*

P

0.922

0.264

Abbreviations: SD: standard deviation; ABS: Ankaferd BloodStopper; NHAA: no haemostatic agent administered, p: protein, GSH:
glutathione, LPO: lipid peroxidation
a
Values are means ± SD.
*P < 0.05 according to Student’s t test
Table 2. Histologic scores of tissue samples on postoperative day 4.
Collagen 4

Collagen 4

VEGF

VEGF

TGF-β

TGF-β

extent

intensity

extent

intensity

extent

intensity

Control - NHAA

-

-

++++

++++

+

+

Control - ABS

++*

++*

++++

++++++*

++

+

STZ - NHAA

-

-

++++

+++++

++

++

STZ - ABS

-

-

++++

+++++

++

+

Abbreviations: ABS: Ankaferd BloodStopper; NHAA: no haemostatic agent administered; VEGF: vascular endothelial growth factor;
TGF-β: transforming growth factor-beta
*Statistically significant according to Student’s t test or the Mann–Whitney U test
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4. Discussion
Many studies have investigated the healing potential of
particular agents in animal models of diabetes, examining
clinical effects or histological outcomes (24–27). ABS has
been used as a local haemostatic agent in surgery, but it
was also shown to promote healing (5,9). Its effects on
soft-tissue healing have been investigated (17,19–21), but
not in a STZ model of diabetes. Therefore, the aim of the
present study was to histologically assess the effects of ABS
on collagen 4, blood GSH levels, and LPO to evaluate its
potential effects in early-stage soft-tissue healing on STZtreated rats.
The STZ group was injected with a single dose of STZ
(60 mg/kg, freshly dissolved in 1 mL of saline solution)
intraperitoneally for 4 days before surgery. Many other
successful STZ administration protocols are described in
the literature (2,28–30).
Collagen, which is beneficial for endoepidermal
growth and therefore healing, is a major functional
extracellular matrix protein in the dermal layer of the skin
(20). Collagen 4, VEGF, and TGF-β are commonly used
markers of healing potential (24,26,27,30–32) and were
evaluated in this study as well. Wound healing comprises
four primary stages that occur in a partly sequential,
partly overlapping process. During the proliferation
(third) phase, fibroblasts migrate from the surrounding
connective tissue, proliferate, and begin to synthesise a
matrix of ground substance, fibronectin, and extracellular
proteins such as collagen, elastin, and integrins. In
addition, macrophages release numerous growth factors
that promote angiogenesis, including basic FGF and
VEGF (33).
Huri et al. applied chitosan and ABS as haemostatic
agents to the excision area in 40 Wistar rats with partial
nephrectomy and found no significant differences in their
effects on haemostasis. They suggested that ABS was just
as effective as other haemostatics, none of which led to
fibrosis, adhesion, or calcification, and all achieved good
histopathological results (34).
Satar et al. compared ABS and oxidised cellulose in
experimentally injured rats. The bleeding time was shorter
in the ABS-treated group, as determined in liver sections.
The favourable histopathological changes included fewer
signs of inflammation than in the oxidised-cellulosetreated group on days 7 and 14 (17).
In a study based on a rat skin defect model, Akalin et
al. reported higher collagen deposition scores and lower
inflammatory scores in the ABS group. The fibroblast
proliferation scores were higher in the ABS group on day
14 (35). The authors suggested that ABS can be safely used
for the repair of full-thickness wounds. Yüce et al. also
recommended ABS to promote wound healing (19).
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Our study demonstrated that, in the control,
nondiabetic animals, collagen 4 extent and intensity
were significantly higher in ABS tissues than in NHAA
tissues (P = 0.021). VEGF scores were also significantly
higher in ABS tissues (P = 0.034). These histologically
based observations suggest that ABS supports wound
healing. Moreover, the extent and intensity of collagen
staining were significantly higher in the ABS tissues of the
control group than in those of the STZ group (P = 0.021),
indicating that ABS did not compensate for the effects of
STZ treatment on wound healing.
Isler et al. examined the effects of ABS on bone healing
during the first 7 days and noted that ABS decreased
inflammation and necrosis and increased new bone
formation (16). Bulut et al. evaluated ABS and routine
antibiotic prophylaxis (AP) on the early healing of bone
defects in diabetic rats but were unable to detect significant
differences in new bone formation between the AP- and
ABS-treated animals (18).
ROS are produced in metabolic and physiological
processes, but in healthy individuals their harmful
oxidative effects are prevented (35) via enzymatic and
nonenzymatic antioxidative mechanisms. A shift in the
oxidative and antioxidative balance towards the former,
as occurs in many disorders including DM, results in
oxidative stress (22,36).
An increase in the concentration of the end products
of LPO is the most prominent evidence of free radical
involvement in human disease (37). However, rather than
accelerating the bulk peroxidation of cell membrane lipids
(22), oxidative stress is likely to cause cell damage, which in
turn leads to a secondary increase in LPO (38). Thus, LPO
is often a late event that accompanies rather than causes
cell death (39). In our study, LPO levels were significantly
increased in the NHAA blood samples but not in the ABS
blood samples of the STZ group (P = 0.0001, P = 0.06,
respectively). Oxidative stress has been associated with
insulin resistance (29) and thus may develop in response
to STZ treatment, resulting in poor soft-tissue healing
(25,29,40–42). The absence of a significant difference in
the blood samples of the ABS-treated rats in the control
versus STZ groups suggests that ABS reduces the oxidative
stress that occurs in DM.
Koluman et al. revealed the presence of several
antioxidant molecules (including tocotrienols, vitamin
E, tryptophan, estriol, galangin, apigenin, oenin,
3,4-divanillyltetrahydrofuran, TBHQ, thymol, BHA,
BHT, lycopene, glycyrrhetinic acid, and tomatine), which
may have clinical implications in the pharmacobiological
actions of ABS. They concluded that the antioxidant
content of ABS should be investigated in future studies
(43).
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Conversely, GSH is part of an integrated antioxidant
system that protects cells and tissues from oxidative
damage (44). In DM, a decrease in tissue GSH could be
due to a decrease in the synthesis of GSH or to an increase
in its degradation by oxidative stress (40). We found that
STZ treatment caused a significant reduction in blood
GSH values, both in ABS-treated and NHAA-treated rats
(P = 0.0001, P = 0.03, respectively).
Aktop et al. found that warfarin treatment in rats
inhibited antioxidant capacity, similar to the treatment
effects of STZ treatment (5). Similar to our own results, in
the control group of their study, there were no statistically
significant differences in GSH and LPO levels in ABStreated versus NHAA-treated tissues (P = 0.051, P = 0.922).
The same authors evaluated catalase and superoxide
dismutase activities in warfarin-treated rats and found
positive effects of ABS on soft-tissue healing (9). In our

study ABS administration improved soft-tissue healing,
consistent with the histologically determined increase in
collagen 4 levels, but there were no significant benefits
with respect to blood GSH and LPO levels.
Aydin et al. applied ABS to the healing tendons of rats
but found no beneficial effects, as determined histologically
(21). Evren et al. reported significantly increased fibrosis
and necrosis in the auricular cartilages of New Zealand
rabbits treated with ABS (45).
In conclusion, STZ treatment may impair soft-tissue
healing in rats by altering the antioxidant–oxidative stress
balance. ABS had histologically confirmed benefits on
wound healing in control rats but not in STZ-treated rats.
Nonetheless, ABS seems to reduce the oxidative stress
associated with diabetic metabolism, based on GSH and
LPO levels that were similar to the control levels.
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